1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- ARTSCAN III : A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer
- 2020
- Health-related quality of life among tonsillar carcinoma patients in Sweden in relation to treatment and comparison with quality of life among the population
- Swedish national multicenter study on head and neck cancer of unknown primary : Prognostic factors and impact of treatment on survival
- 2016
- Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up.
- 2015
- Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
- 2011
-
Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma The ARTSCAN study
Zackrisson, Bjorn ; Nilsson, Per LU
; Kjellén, Elisabeth
LU
; Johansson, Karl-Axel
; Modig, Hans
; Brun, Eva
LU
; Nyman, Jan
; Friesland, Signe
; Reizenstein, Johan
and Sjodin, Helena
, et al.
(2011)
In Radiotherapy and Oncology
100(1).
p.41-48
Mark